Robert L. Little
2008
In 2008, Robert L. Little earned a total compensation of $417.1K as Vice President and Chief Commercial Officer at Halozyme Therapeutics, a 4% decrease compared to previous year.
Compensation breakdown
| Option Awards | $94,726 |
|---|---|
| Salary | $322,000 |
| Other | $392 |
| Total | $417,118 |
Little received $322K in salary, accounting for 77% of the total pay in 2008.
Little also received $94.7K in option awards and $392 in other compensation.
Rankings
In 2008, Robert L. Little's compensation ranked 7,042nd out of 9,135 executives tracked by ExecPay. In other words, Little earned more than 22.9% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 7,042 out of 9,135 | 23rd |
Division Manufacturing | 2,636 out of 3,436 | 23rd |
Major group Chemicals And Allied Products | 593 out of 815 | 27th |
Industry group Drugs | 417 out of 597 | 30th |
Industry Biological Products, Except Diagnostic Substances | 71 out of 118 | 40th |
Source: SEC filing on March 24, 2011.
Little's colleagues
We found six more compensation records of executives who worked with Robert L. Little at Halozyme Therapeutics in 2008.
2008
Jonathan Lim
Halozyme Therapeutics
Chief Executive Officer
2008
Gregory Frost
Halozyme Therapeutics
Chief Executive Officer
2008
Michael LaBarre
Halozyme Therapeutics
Vice President, Product Development
2008
Richard Yocum
Halozyme Therapeutics
Vice President — Clinical Development and Medical Affairs
2008
William Fallon
Halozyme Therapeutics
Vice President, Manufacturing & Operations
2008
David Ramsay
Halozyme Therapeutics